Apontis Pharma AG (FRA:APPH)
Germany
· Delayed Price · Currency is EUR 10.95
0.00 (0.00%)
At close: May 30, 2025, 10:00 PM CET
Apontis Pharma AG Revenue
In the year 2024, Apontis Pharma AG had annual revenue of 48.47M EUR with 31.12% growth. Apontis Pharma AG had revenue of 25.74M in the half year ending December 31, 2024, a decrease of -4.90%.
Revenue
48.47M
Revenue Growth
+31.12%
P/S Ratio
2.03
Revenue / Employee
353.78K
Employees
137
Market Cap
98.29M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.15B |
| Siemens Aktiengesellschaft | 77.82B |
| Deutsche Telekom AG | 120.25B |
| Allianz SE | 107.35B |
| Rheinmetall AG | 10.48B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
| Siemens Energy AG | 37.44B |
| Deutsche Börse AG | 5.95B |
Apontis Pharma AG News
- 2 months ago - APONTIS PHARMA: Big 2024 Gains & Merger Plans Ahead! - Wallstreet:Online
- 2 months ago - EQS-News: APONTIS PHARMA with significant sales and earnings increase in 2024 financial year – squeeze-out and merger planned - Wallstreet:Online